The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the battlefield.
Specifically, under this award Harvard Medical School will use artificial intelligence to predict pancreatic cancer risk by analyzing electronic health records in U.S. veterans. As the prime recipient, Harvard Medical School will leverage its expertise in quantitative analysis, bioinformatics and other specialties to conduct the research independently. Relevant contextual details include that the Defense Health Agency has previously supported Harvard Medical School research on biomarkers of sleep loss in service members, demonstrating the alignment of this award with the federal grant program's goals.
Generated 2/20/24, 6:19 AM